Kim Chi, MD, FRCPC, discusses the rationale and design of the phase 3 KLK2-comPAS trial evaluating pasritamig alone and in combination with JNJ-9401 in patients with mCRPC.
|Videos|September 16, 2020
Effect of an online opioid training course on prescription patterns for urologic surgeries
Author(s)Urology Times staff
Meena Davuluri, MD, MPH, and Kara L. Watts, MD, discuss findings from a study published in Urology Practice.
Advertisement
In this interview, Meena Davuluri, MD, MPH, and Kara L. Watts, MD, discuss a recent Urology Practice study, “Impact of Mandated Opioid Online Training Course: Does It Impact Opioid Prescription Patterns for Outpatient Endoscopic Urologic Surgeries,” for which they served as study authors. Davuluri is a health care outcomes and research fellow at Weill Cornell Medicine Urology and clinical instructor of urology at NewYork Presbyterian Brooklyn Methodist Hospital, and Watts is assistant professor of urology at Montefiore Medical Center.
Advertisement
Related to this article
Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.
Michael S. Cookson, MD, MMHC, FACS, discusses how Anktiva’s expanded FDA approval may broaden bladder-preserving treatment options for BCG-unresponsive papillary-only NMIBC.
Jeffrey M. Spier, MD, reviews evidence on ARPI dose reduction in prostate cancer and discusses monitoring treatment response, tolerability, and dose reescalation.
Jeffrey M. Spier, MD, discusses managing ARPI-related fatigue through dose adjustments, patient monitoring, and strategies to maintain treatment adherence.
Sandip M. Prasad, MD, MPhil, discusses the safety profile of mitomycin intravesical solution, including common adverse events and patient counseling during chemoablation for NMIBC.
Sandip M. Prasad, MD, MPhil, discusses 3-year ENVISION trial data showing durable responses with mitomycin intravesical solution for recurrent LG-IR-NMIBC.
Armine K. Smith, MD, discusses sexual health counseling, sex-specific considerations, and organ-preserving approaches for patients undergoing radical cystectomy.
Advertisement
Advertisement
Trending on Urology Times
1
Darolutamide associated with less cognitive change than enzalutamide in prostate cancer
2
ESMO 2026: Key presentations across genitourinary oncology
3
KLK2-comPAS trial explores dual T-cell engagement in mCRPC
4
Gedatolisib plus darolutamide shows preliminary activity in mCRPC
5